Table of Contents Table of Contents
Previous Page  410 / 1082 Next Page
Information
Show Menu
Previous Page 410 / 1082 Next Page
Page Background

S395

ESTRO 36 2017

_______________________________________________________________________________________________

Conclusion

It was determined that the four testing materials were

MR/CT compatible, showed expected PDD curves, and

preliminary data show expected beam profiles with and

without 1.5T on the MR-Linac.

PO-0757 Variation of mean dose output from 204 UK

linacs (Jan-June 2015) and its potential clinical impact.

M. Bolt

1

, A. Nisbet

1

, C. Clark

2

, T. Chen

3

, R. Jena

4

1

St. Luke's Cancer Centre Royal Surrey County Hosp,

Radiotherapy Physics, Guildford, United Kingdom

2

National Physical Laboratory, Radiation Dosimetry,

Teddington, United Kingdom

3

University of Surrey, Chemical and Process Engineering,

Guildford, United Kingdom

4

Addenbrooke's Hospital, Department of Oncology,

Cambridge, United Kingdom

Purpose or Objective

Variation in dose delivered to patients directly impacts

the effectiveness of radiotherapy treatments. The drift

and daily fluctuations in linac beam calibration (output) is

a contributing factor to the cumulative dose received by

the patient. Knowledge of the variation in measured

outputs on a national scale provides an insight into the

uncertainties in dose delivery and its clinical impact.

Material and Methods

A request for 6MV output measurement data was sent to

all UK radiotherapy centres. In total, data was provided

for 204 linacs situated at 52 cancer centres across the UK.

The data spans 6 months from January to June 2015,

totalling almost 25,000 data points. Additional data

collected includes: linac model, year of install,

measurement equipment and recording method.

The dose response parameter, gamma, is the percentage

change in treatment response caused by a percentage

change in dose. Gamma values of 2.3 and 5.2

(representative for Head and Neck cancers) were used to

estimate the effect on TCP and NTCP respectively [1].

Results

Based on the collated data, the UK linac outputs had a

mean of -0.01% with one standard deviation of 0.88%.

There was a wide variety of recording methods, with 8

centres having no form of electronic record for daily

checks. Measurement data for both constancy devices and

ionisation chambers was provided for 29 linacs. Of these,

8 (28%) had a discrepancy between measurement devices

of greater than 0.5%, with 3 linacs (10%) having greater

than 1%.

The greatest variation in the mean output of an individual

linac was -2.1%, with 90% of linacs having a mean output

within 1%of the national mean. No significant variations

were observed based on the age of the linac.

The maximum range within a single centre for the mean

output for each linac was 2.3% (min:-1.1%, max:+1.2%) –

see figure. Assuming patients are treated on a single linac

for their treatment duration, this indicates a variation in

TCP of 5.3% and a variation in NTCP of 12% dependent on

which linac they are treated on at that centre.

Conclusion

The data collection process indicates that many

departments still rely heavily on paper QC records. The

variation in treatment outcomes caused by dose variation

alone indicates the importance of accurate QC. Output

adjustment is one of the simplest ways of maintaining

treatment consistency between individual patients, and

its significance should not be forgotten with the

introduction of more advanced techniques. This variation

in dose should be considered when participating in clinical

trials. This applies both to small scale local trials in which

the technique used may determine the treatment linac,

and therefore the dose delivered, as well as large multi-

centre trials where the dose variation should be

considered for the trial power calculations.

[1] Bentzen, S.M et al. (2000), Eur J Cancer, Mar: 36(5):

pp.615-620.

PO-0758 Development of patient-specific phantoms for

verification of SBRT planning using 3D printer

C.S. Hong

1

, D. Oh

1

, S.G. Ju

1

, M. Kim

1

, B.Y. Koo

1

, H.C.

Park

1

, D.H. Choi

1

, H. Pyo

1

1

Samsung Medical Center- Samsung Biomedical Research

Institute- Sungkyunkwan University School of Medicine,

Radiation Oncology, Seoul, Korea Republic of

Purpose or Objective

A new technique for manufacturing a patient-specific

dosimetric phantom (PSDP) using three-dimensional

printing (PSDP_3DP) was developed, and its geometrical

and dosimetric accuracy was analyzed.

Material and Methods

External body contours and structures of the spine and

metallic fixation screws (MFS) were delineated from CT

images of a patient with MFS who underwent stereotactic

body radiation therapy for recurrent thoracic spine

metastasis. Contours were converted into a

STereoLithography file format using in-house program. A

hollow, four-section PSDP was designed and manufactured

using three types of 3DP to allow filling with a muscle-

equivalent liquid and insertion of dosimetric film and grass

dosimeters in the axial and coronal planes, respectively.

To evaluate the geometrical and dosimetric accuracy of

PSDP_3DP, CT images were obtained and compared with

patient CT data for volume, mean density, and Dice

similarity coefficient (DSC) for contours. The dose

distribution in the PSDP_3DP was calculated by applying

the same beam parameters as for the patient, and the